Frontlight ResearchEarly access
Taking people in CzechiaPhase 1
Tests a new pill in adults with advanced solid tumors
Tests a new pill in adults with advanced cancers after standard treatment fails.
Key facts
- Who runs it
- VUAB Pharma a.s.
- Where
- Brno-Stred, CzechiaSee the site
- Registry title
- Trial of the novel peroral anti-tumor treatment in patients with solid tumors
- Status
- Recruiting
- Phase
- Phase 1
- People taking part
- 30 people, planned
- Started
- 7 Jun 2022
- Expected to end
- 31 Dec 2026
- Type of study
- Interventional
- Record updated
- 4 September 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with advanced solid tumors who have no standard treatment left, or for whom standard treatment has failed. It tests a new treatment taken by mouth.
- Age
- 18 years or older
- Sex
- All sexes can join.
- Disease stage
- Metastatic or locally advanced solid tumors with no standard therapy, or where standard therapy has failed. Tumor types named: lung, head and neck, colon, stomach, esophagus, breast, ovary and/or fallopian tube, or primary peritoneal high-grade serous carcinoma.
- Earlier treatment
- Standard therapy must have failed or must not exist.
Where in Czechia
- Masarykuv Onkologicky UstavBrno-Stred, CzechiaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorData and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
- Plain-language title
- Tests a new pill in adults with advanced solid tumorsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 9 November 2026.
- Record updated
- 4 September 2026